Log inSign up
Sia Daneshmand, M.D.
1,316 posts
user avatar
Sia Daneshmand, M.D.
@siadaneshmand
Professor of Urology and Oncology (Clinical Scholar) Director of Urologic Oncology Director of Clinical Research Urologic Oncology Fellowship Director USC
Los Angeles, CA
Joined June 2009
720
Following
5,007
Followers
  • Pinned
    user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Dec 28, 2018
    Huge fan of robot & love doing RALP/partial nx but agree modern Uro Onc needs training in complex open sx (redos, ext LOA, re-diversions, hi level thrombus, large masses, complex PC RPLNDs) Who will do in future? Early Gen surg training won’t help. Need to train future fellows.
    user avatar
    Ryan Werntz
    @RyanWerntzMD
    Dec 28, 2018
    The robot has taken over urologic cancer surgery in many training environments...open sx and re-operative sx is becoming a lost art. think we either need open fellowships or more time in general surgery moving forward? @uroegg @ZacharySmithMD @theVig245 @siadaneshmand @PearceMD
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Mar 14, 2023
    SEMS trial finally published! ⬆️data RPLND for early Stage II Seminoma is efficacious w/ min short & long term morbidity. Collaborators @IUuro @nabiladra @SBoorjian @pcvblack @uroegg @drphil_urology @kellystratton @LuciaNappi4 @Testiscancer @GU_BigWhacks
    Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for...
    From pubmed.ncbi.nlm.nih.gov
    37K
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Aug 6, 2023
    Humbled and proud to be appointed organ site chair for bladder cancer (local) within the @SWOG Genitourinary Committee. Looking forward to working with @TomFlaigMD & Seth Lerner & rest of @SWOG GU committee to further advance #bladdercancer care through innovative trial protocols
    16K
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Nov 13, 2021
    It takes 2 years with 2 weavers working 6986 hours (over 4.3 million knots) to create this masterpiece from Qom, Iran. #persianrugs
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Jul 30, 2025
    Just published online in @JCO_ASCO : #SunRISe1 Phase IIb results show TAR-200 (novel intravesical drug releasing system) achieves 82.4% CR in BCG-unresponsive high-risk NMIBC—with durable responses (median DOR 25.8 mo) & low toxicity. A game-changer for pts with #NMIBC.
    ascopubs.org
    TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer:...
    PURPOSETAR-200 is a first-in-class intravesical drug-releasing system designed to provide sustained delivery of gemcitabine in the bladder. TAR-200 alone or in combination with cetrelimab (PD-1...
    22K
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Mar 29, 2019
    ⚡️ “TURBT” by @siadaneshmand x.com/i/moments/1111…
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Mar 15, 2025
    When teaching control of a significant bleed during surgery I tell trainees “Don’t lose exposure … or your composure”. Excellent essay written a few years ago by @WesleyYipMD for @AmerUrological on the other perspective. We need more realistic training models.
    14K
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Oct 3, 2024
    Tremendous effort by @slernerbcmedu1 & colleagues on this @SWOG S1011 trial. Practice changing trial. Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer nejm.org/doi/full/10.10… @SvatekRob @PoharKamal @AnneSchuckmanMD @UroDocAsh @montypal @garysteinbergmd
    nejm.org
    Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer | NEJM
    Whether extended lymphadenectomy is associated with improved disease-free and overall survival, as compared with standard lymphadenectomy, among patients with localized muscle-invasive bladder canc...
    10K
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    May 5, 2024
    Midline extraperitoneal #RPLND (primary or post chemo) reduces surgical morbidity, eliminates ileus with short hospital stay (contemporary 90% discharge POD #1) @saumyg @GU_BigWhacks @UroAlsyouf @SHPatelMD1 @HamedA3112 @AdityaBagrodia @RHamiltonUrol
    00:00
    user avatar
    Alireza Ghoreifi, MD
    @alirezaghoreifi
    May 5, 2024
    🎉🎊Congratulations to @siadaneshmand and team @UroAlsyouf @erikaloulou @LeileiXiaUro for winning the BEST VIDEO presentation at #AUA24 on their work on EP-RPLND for testicular cancer. @USC_Urology @AmerUrological
    14K
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    May 3, 2024
    Impressive results presented by @JoeJacobMD1 at #AUA2024 from SunRISE-1 trial showing 82.8% CR rate at anytime and 12mo DOR 74.6%. Well tolerated. @AndreaNecchi @Sweiti @IBCG_BladderCA @BladderCancerUS
    10K
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Oct 9, 2022
    Iranian women are among the most educated and accomplished around the world. Help support the movement #mahsaamini #womenofiran #womensrights #iranpotests
    Adrienne Youdim MD (@dradrienneyoudim) • Instagram photo
    From instagram.com
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Feb 7, 2021
    #TURBT is a common and deceptively challenging operation. Tips to achieve optimal outcomes. @ahmostafid @UroDocAsh @joanfundi @JimCatto @JamesJmm23 @MarekBabjuk @BladderCancerUS authors.elsevier.com/c/1cXmI9Cfv-nW…
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Jun 14, 2025
    A true honor to serve as VP @rwjurology. Incredible division led by empowering @TomJangUroOnc with star faculty @saumyg @VigneshPackiam @DGolombos @RoboUroMD @CChangUro Danielle Leitner. Excited for future of stunning new @RutgersCancer Center. Thx to all residents for
    user avatar
    Thomas Jang
    @TomJangUroOnc
    Jun 13, 2025
    What a treat to host the inimitable @siadaneshmand @USC_Urology as our center's 2025 @rwjurology @RutgersCancer #Urology Visiting Prof! His journey & impact on our field incredibly inspiring #UroSoMe @NYSAUA @UroOnc @TestesCancer @BladderCancerUS @IBCG_BladderCA @AmerUrological
    7.5K
  • user avatar
    Sia Daneshmand, M.D.
    @siadaneshmand
    Nov 8, 2019
    Delay to #cystectomy never good but particularly worse in pts w variant histology. Every mo delay associated w worse overall survival. @BladderCancerUS @urogoldjournal @syan_sumeet @AnneSchuckmanMD @Hoomandjaladat @pcvblack @PGrivasMDPhD @UroDocAsh sciencedirect.com/science/articl…

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up